These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16177872)

  • 1. Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?
    Kopp R; Diebold J; Dreier I; Cramer C; Glas J; Baretton G; Jauch KW
    Surg Endosc; 2005 Nov; 19(11):1507-12. PubMed ID: 16177872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
    Wolf HK; Stöber C; Hohenfellner R; Leissner J
    Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of biological apoptosis factors in gastric cancer.
    Sezer C; Yildirim M; Yildiz M; Sezgin A; Donem Dilli U; Goktas S; Bulbuller N
    J BUON; 2013; 18(1):138-46. PubMed ID: 23613399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.
    Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C
    Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
    Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
    Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas.
    Barresi V; Branca G; Ieni A; Rigoli L; Tuccari G; Caruso RA
    World J Gastroenterol; 2015 May; 21(18):5548-54. PubMed ID: 25987778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of bcl-2 expression in gastric cancer.
    Müller W; Schneiders A; Hommel G; Gabbert HE
    Anticancer Res; 1998; 18(6B):4699-704. PubMed ID: 9891543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
    Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and Bbcl-2 expression in gastric carcinomas: correlation withclinicopathological variables, p53 expression, cell proliferation and prognosis.
    Aizawa K; Ueki K; Suzuki S; Yabusaki H; Kanda T; Nishimaki T; Suzuki T; Hatakeyama K
    Int J Oncol; 1999 Jan; 14(1):85-91. PubMed ID: 9863013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
    Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
    Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
    Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of apoptosis inducers/inhibitors in stomach carcinoma with/without adjuvant intraoperative radiotherapy (IORT)].
    Kopp R; Krämling HJ; Cramer C; Diebold J; Baretton G; Schildberg FW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1360-2. PubMed ID: 9931882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.
    Tokunaga M; Ito S; Yoshikawa T; Nunobe S; Fukagawa T; Misawa K; Cho H; Katai H; Sano T; Terashima M
    Br J Surg; 2017 Jun; 104(7):885-890. PubMed ID: 28240355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in prostate cancer.
    Stattin P
    Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.